Edwards Lifesciences Corporation Common Stock

Financials

영업활동으로 인한 현금 -127.5 M280.4 M290.2 M573.7 M450.9 M43.8 M 1.36 B 투자 활동으로 인한 현금 -576.7 M85.3 M-172.1 M-427.8 M-198.3 M-92.8 M -891 M 재무활동으로 인한 현금 28.6 M-258 M52.7 M-740.1 M-11.4 M-451.2 M -1.15 B 잉여 현금 흐름 -127.5 M280.4 M240.9 M516.2 M353.5 M-21.1 M 1.09 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

EW

Financials

Edwards Lifesciences Corporation Common Stock

뉴스

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)

Top Research Reports for Philip Morris, Honeywell & Starbucks

Artisan Global Opportunities Fund Q1 2026 Portfolio Activity

Medtronic: Expectations Are Low And That's The Opportunity (NYSE:MDT)

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

S&P 500 and Nasdaq Post Record Highs on Tech Stock Strength and Iran Diplomacy

EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs